We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Netscientific Plc | LSE:NSCI | London | Ordinary Share | GB00BN4R5Q82 | ORD 5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 63.00 | 61.00 | 65.00 | 63.00 | 63.00 | 63.00 | 15,341 | 07:36:40 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 1M | -3.09M | -0.1312 | -4.80 | 14.85M |
From Apr 2019 to Apr 2024
TIDMNSCI
RNS Number : 4275G
NetScientific PLC
26 May 2017
NetScientific plc
("NetScientific" or the "Company" or the "Group")
Notice of AGM and Annual Report & Accounts
London, UK - May 26(th) 2017 - NetScientific plc (AIM:NSCI), the transatlantic healthcare IP commercialisation Group announces that, in accordance with AIM Rules 20 and 26, the Group's Annual Report and Accounts for the year ended 31 December 2016 and Notice of Annual General Meeting have been sent to shareholders today and are available on the Company's website in the Investor Relations section at http://www.netscientific.net/investors.
The Annual General Meeting of the Group will be held on Wednesday, 21 June 2017 at 11.00 a.m. at DLA Piper UK LLP, 3 Noble Street, London EC2V 7EE, United Kingdom.
# # #
For more information, please contact:
NetScientific Tel: +44 (0)20 3514 1800 François R. Martelet, M.D., CEO Ian Postlethwaite, CFO Consilium Strategic Communications Tel: +44 (0)20 3709 5700 Mary-Jane Elliott Jessica netscientific@consilium-comms.com Hodgson / Chris Welsh / Laura Thornton Stifel Nicolaus Europe Tel: +44 (0) 20 7710 7600 Limited (NOMAD and Broker) Jonathan Senior / David Arch / Ben Maddison
About NetScientific
NetScientific is an IP commercialisation group focused on healthcare with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.netscientific.net
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEALSKASEXEFF
(END) Dow Jones Newswires
May 26, 2017 10:52 ET (14:52 GMT)
1 Year Netscientific Chart |
1 Month Netscientific Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
